{"entity":{"type":"insider","cik":"0001421050","url":"/insider/0001421050","json_url":"/insider/0001421050.json","name":"Mammen Mathai","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":13,"n_filings":9,"first":"2010-09-02","last":"2023-05-15","span_basis":"filed_date"},"name_variants":[{"name":"Mammen Mathai","source":"filing","n_filings":9,"first_seen":"2010-09-02","last_seen":"2023-05-15"}],"transactions":[{"id":8181162,"accession":"0001610717-23-000035","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001610717-23-000035","line_url":"/filing/0001610717-23-000035#line-2","is_derivative":false,"issuer_cik":"0001421050","issuer_name":"10x Genomics, Inc.","issuer_ticker":"TXG","issuer_name_source":null,"issuer_url":"/issuer/0001421050","owner_cik":"0001421050","owner_name":"Mammen Mathai","owner_display_name":"Mammen Mathai","owner_url":"/insider/0001421050","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":33000.0,"shares_display":"33,000","price_per_share":52.8208,"price_display":"52.82","price_state":"stated","total_value":1743086.4,"total_display":"1,743,086.40","total_whole":"1,743,086","shares_owned_after":169745.0,"shares_owned_after_display":"169,745","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-05-11","filed_date":"2023-05-15","scope":"insider"},{"id":6547270,"accession":"0001179110-14-003128","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-14-003128","line_url":"/filing/0001179110-14-003128","is_derivative":false,"issuer_cik":"0001080014","issuer_name":"THERAVANCE INC","issuer_ticker":"THRX","issuer_name_source":null,"issuer_url":"/issuer/0001080014","owner_cik":"0001421050","owner_name":"Mammen Mathai","owner_display_name":"Mammen Mathai","owner_url":"/insider/0001421050","role":"Officer (SVP, Research & Early Clin Dev)","role_mark":"O","role_mark_label":"Officer (SVP, Research & Early Clin Dev)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Research & Early Clin Dev","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":35000.0,"shares_display":"35,000","price_per_share":39.36251428571428,"price_display":"39.36","price_state":"stated","total_value":1377688.0,"total_display":"1,377,688.00","total_whole":"1,377,688","shares_owned_after":191223.0,"shares_owned_after_display":"191,223","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-02-14","filed_date":"2014-02-19","scope":"insider","n_lines":2},{"id":4277591,"accession":"0001179110-13-012478","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-13-012478","line_url":"/filing/0001179110-13-012478#line-1","is_derivative":false,"issuer_cik":"0001080014","issuer_name":"THERAVANCE INC","issuer_ticker":"THRX","issuer_name_source":null,"issuer_url":"/issuer/0001080014","owner_cik":"0001421050","owner_name":"Mammen Mathai","owner_display_name":"Mammen Mathai","owner_url":"/insider/0001421050","role":"Officer (SVP, Research & Early Clin Dev)","role_mark":"O","role_mark_label":"Officer (SVP, Research & Early Clin Dev)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Research & Early Clin Dev","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7000.0,"shares_display":"7,000","price_per_share":36.51,"price_display":"36.51","price_state":"stated","total_value":255570.0,"total_display":"255,570.00","total_whole":"255,570","shares_owned_after":211705.0,"shares_owned_after_display":"211,705","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-07-30","filed_date":"2013-08-01","scope":"insider"},{"id":4813912,"accession":"0001179110-13-007592","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-13-007592","line_url":"/filing/0001179110-13-007592","is_derivative":false,"issuer_cik":"0001080014","issuer_name":"THERAVANCE INC","issuer_ticker":"THRX","issuer_name_source":null,"issuer_url":"/issuer/0001080014","owner_cik":"0001421050","owner_name":"Mammen Mathai","owner_display_name":"Mammen Mathai","owner_url":"/insider/0001421050","role":"Officer (SVP, Research & Early Clin Dev)","role_mark":"O","role_mark_label":"Officer (SVP, Research & Early Clin Dev)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Research & Early Clin Dev","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7000.0,"shares_display":"7,000","price_per_share":33.73771428571428,"price_display":"33.74","price_state":"stated","total_value":236164.0,"total_display":"236,164.00","total_whole":"236,164","shares_owned_after":206176.0,"shares_owned_after_display":"206,176","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-04-30","filed_date":"2013-05-02","scope":"insider","n_lines":2},{"id":5061716,"accession":"0001179110-13-003416","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-13-003416","line_url":"/filing/0001179110-13-003416#line-2","is_derivative":false,"issuer_cik":"0001080014","issuer_name":"THERAVANCE INC","issuer_ticker":"THRX","issuer_name_source":null,"issuer_url":"/issuer/0001080014","owner_cik":"0001421050","owner_name":"Mammen Mathai","owner_display_name":"Mammen Mathai","owner_url":"/insider/0001421050","role":"Officer (SVP, Research & Early Clin Dev)","role_mark":"O","role_mark_label":"Officer (SVP, Research & Early Clin Dev)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Research & Early Clin Dev","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7000.0,"shares_display":"7,000","price_per_share":22.14,"price_display":"22.14","price_state":"stated","total_value":154980.0,"total_display":"154,980.00","total_whole":"154,980","shares_owned_after":212976.0,"shares_owned_after_display":"212,976","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-02-20","filed_date":"2013-02-22","scope":"insider"},{"id":2297947,"accession":"0001179110-12-015745","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-12-015745","line_url":"/filing/0001179110-12-015745","is_derivative":false,"issuer_cik":"0001080014","issuer_name":"THERAVANCE INC","issuer_ticker":"THRX","issuer_name_source":null,"issuer_url":"/issuer/0001080014","owner_cik":"0001421050","owner_name":"Mammen Mathai","owner_display_name":"Mammen Mathai","owner_url":"/insider/0001421050","role":"Officer (SVP, Research & Early Clin Dev)","role_mark":"O","role_mark_label":"Officer (SVP, Research & Early Clin Dev)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Research & Early Clin Dev","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7000.0,"shares_display":"7,000","price_per_share":21.451714285714285,"price_display":"21.45","price_state":"stated","total_value":150162.0,"total_display":"150,162.00","total_whole":"150,162","shares_owned_after":205841.0,"shares_owned_after_display":"205,841","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-11-02","filed_date":"2012-11-06","scope":"insider","n_lines":2},{"id":2418847,"accession":"0001179110-12-012947","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-12-012947","line_url":"/filing/0001179110-12-012947","is_derivative":false,"issuer_cik":"0001080014","issuer_name":"THERAVANCE INC","issuer_ticker":"THRX","issuer_name_source":null,"issuer_url":"/issuer/0001080014","owner_cik":"0001421050","owner_name":"Mammen Mathai","owner_display_name":"Mammen Mathai","owner_url":"/insider/0001421050","role":"Officer (SVP, Research & Early Clin Dev)","role_mark":"O","role_mark_label":"Officer (SVP, Research & Early Clin Dev)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Research & Early Clin Dev","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":25.7384304,"price_display":"25.74","price_state":"stated","total_value":643460.76,"total_display":"643,460.76","total_whole":"643,461","shares_owned_after":215393.0,"shares_owned_after_display":"215,393","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-08-13","filed_date":"2012-08-15","scope":"insider","n_lines":2},{"id":8876151,"accession":"0001179110-11-003308","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-11-003308","line_url":"/filing/0001179110-11-003308#line-1","is_derivative":false,"issuer_cik":"0001080014","issuer_name":"THERAVANCE INC","issuer_ticker":"THRX","issuer_name_source":null,"issuer_url":"/issuer/0001080014","owner_cik":"0001421050","owner_name":"Mammen Mathai","owner_display_name":"Mammen Mathai","owner_url":"/insider/0001421050","role":"Officer (SVP, Research & Early Clin Dev)","role_mark":"O","role_mark_label":"Officer (SVP, Research & Early Clin Dev)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Research & Early Clin Dev","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3701.0,"shares_display":"3,701","price_per_share":23.12,"price_display":"23.12","price_state":"stated","total_value":85567.12,"total_display":"85,567.12","total_whole":"85,567","shares_owned_after":252622.0,"shares_owned_after_display":"252,622","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-02-18","filed_date":"2011-02-23","scope":"insider"},{"id":7322015,"accession":"0001179110-10-013469","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-10-013469","line_url":"/filing/0001179110-10-013469#line-1","is_derivative":false,"issuer_cik":"0001080014","issuer_name":"THERAVANCE INC","issuer_ticker":"THRX","issuer_name_source":null,"issuer_url":"/issuer/0001080014","owner_cik":"0001421050","owner_name":"Mammen Mathai","owner_display_name":"Mammen Mathai","owner_url":"/insider/0001421050","role":"Officer (SVP, Research & Early Clin Dev)","role_mark":"O","role_mark_label":"Officer (SVP, Research & Early Clin Dev)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Research & Early Clin Dev","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4416.0,"shares_display":"4,416","price_per_share":12.84,"price_display":"12.84","price_state":"stated","total_value":56701.44,"total_display":"56,701.44","total_whole":"56,701","shares_owned_after":117566.0,"shares_owned_after_display":"117,566","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-09-01","filed_date":"2010-09-02","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":13,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":13,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":13},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001770787","name":"10x Genomics, Inc.","url":"/issuer/0001770787","role":"Director","n_filings":1,"first_seen":"2023-05-15","last_seen":"2023-05-15"},{"type":"issuer","type_label":"ISSUER","cik":"0001080014","name":"THERAVANCE INC","url":"/issuer/0001080014","role":"Officer (SVP, Research & Early Clin Dev)","n_filings":8,"first_seen":"2010-09-02","last_seen":"2014-02-19"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001421050","retrieved_at":"2026-08-27T09:27:18+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-26","last_ingest":"2026-08-27T05:24:39.644631+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}